Literature DB >> 17785513

Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.

Yohei Doi1, Jennifer M Adams, Kunikazu Yamane, David L Paterson.   

Abstract

Five highly amikacin-resistant Acinetobacter baumannii isolates were collected at a medical center in Pennsylvania. The aminoglycoside resistance was due to the production of the 16S rRNA methylase ArmA. Two of the isolates coproduced OXA-23 beta-lactamase and were highly resistant to carbapenems as well. The isolates were genetically closely related by pulsed-field gel electrophoresis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17785513      PMCID： PMC2151453          DOI： 10.1128/AAC.00560-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

2.  Genetic basis for dissemination of armA.

Authors:  Bruno González-Zorn; Ana Catalan; Jose A Escudero; Lucas Domínguez; Tirushet Teshager; Concepción Porrero; Miguel Angel Moreno
Journal:  J Antimicrob Chemother       Date:  2005-07-18       Impact factor: 5.790

Review 3.  ISCR elements: novel gene-capturing systems of the 21st century?

Authors:  Mark A Toleman; Peter M Bennett; Timothy R Walsh
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

Review 4.  The epidemiology and control of Acinetobacter baumannii in health care facilities.

Authors:  Pierre Edouard Fournier; Hervé Richet
Journal:  Clin Infect Dis       Date:  2006-01-26       Impact factor: 9.079

5.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

6.  Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548.

Authors:  M Galimand; S Sabtcheva; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).

Authors:  Samuel K Bouchillon; Daryl J Hoban; Brian M Johnson; Jack L Johnson; Andre Hsiung; Michael J Dowzicky
Journal:  Diagn Microbiol Infect Dis       Date:  2005-07       Impact factor: 2.803

9.  In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).

Authors:  Daryl J Hoban; Samuel K Bouchillon; Brian M Johnson; Jack L Johnson; Michael J Dowzicky
Journal:  Diagn Microbiol Infect Dis       Date:  2005-07       Impact factor: 2.803

Review 10.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Authors:  K J Shaw; P N Rather; R S Hare; G H Miller
Journal:  Microbiol Rev       Date:  1993-03
View more
  27 in total

1.  Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.

Authors:  Yohei Doi; Jennifer M Adams-Haduch; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

Review 2.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

3.  Identification of the aminoglycoside resistance determinants armA and rmtC among non-Typhi Salmonella isolates from humans in the United States.

Authors:  Jason P Folster; Regan Rickert; Ezra J Barzilay; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

4.  Diversity of High-Level Aminoglycoside Resistance Mechanisms among Gram-Negative Nosocomial Pathogens in Brazil.

Authors:  Anelise S Ballaben; Leonardo N Andrade; Renata Galetti; Joseane C Ferreira; Christi L McElheny; Roberta T Mettus; Paulo da Silva; Doroti de Oliveira Garcia; Ana Lucia C Darini; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

5.  Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides.

Authors:  Y Zhou; H Yu; Q Guo; X Xu; X Ye; S Wu; Y Guo; M Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-08       Impact factor: 3.267

Review 6.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

7.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

8.  Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America.

Authors:  Thomas R Fritsche; Mariana Castanheira; George H Miller; Ronald N Jones; Eliana S Armstrong
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 10.  Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

Authors:  A M Richards; Y Abu Kwaik; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2014-09-27       Impact factor: 3.563
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.